Tapestry Pharmaceuticals, Inc.

(NASDAQ:TPPH)
  Sep 30, 2007
Operating revenue
Total Revenue
Operating Revenue
Adjustments To Revenue
Cost Of Sales -47
Cost Of Sales With Depreciation
Gross Operating Profit 47
Operating Expenses
Research And Development Expenses 4,526
Selling General And Administrative Expenses 1,737
Advertising Expenses
Operating Income Before Depreciation -6,216
Operating Income -6,263
Depreciation 47
Depreciation Unreconciled
Amortization
Amortization Of Intangibles
Operating Income After Depreciation -6,263
Non Operating Expenses
Interest Expense 6
Pre Tax Income -6,100
Income Taxes
Minority Interest
Income Before Income Taxes
Net Income From Continuing Operations -6,100
Net Income From Discontinued Operations
Net Income From Total Operations -6,100
Non Recurring Events
Extraordinary Income Losses
Income From Cummulated Effect Of Accounting Changes
Income From Tax Loss Carryforward
Other Gains And Losses
Total Net Income -6,100
Normalized Income -6,100
NetIncome Available For Common -6,100
Preferred Dividends
Excise Taxes